Item 7.01    Regulation FD Disclosure.

Tonix Pharmaceuticals Holding Corp. (the "Company") will present certain information regarding its product candidates (the "Presentation") at the 2023 Biotech Showcase being held January 9, 2023 to January 11, 2023. The Presentation, which may contain nonpublic information, is filed as Exhibit 99.01 hereto and incorporated herein by reference.

The information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.01 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the United States Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the United States Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.






(d)    Exhibit
         No.                                  Description.
        99.01       Presentation by the Company
         104      Cover Page Interactive Data File (embedded within the Inline XBRL
                  document)

© Edgar Online, source Glimpses